HDAC9 and cancer: Panobinostat, an HDAC inhibitor, is considered one of the most promising drugs for cancer treatment because its HDAC inhibitors induce cancer cell cycle arrest, cause differentiation and cell death, reduce angiogenesis, and regulate the DNA-damage response [50].